Suchergebnisse

347 Artikel wurden gefunden.

Die folgenden Begriffe wurden einbezogen: Glioblastom, glioblastoma, 神経膠細胞芽腫

• 2016, Hottinger AF, Pacheco P, Stupp R
  Tumor treating fields: a novel treatment modality and its use in brain tumors [Grundlagen]
  Neuro Oncol 18 (10): 1338-1349
• 2016, Chamberlain MC
  Treatment for Patients With Newly Diagnosed Glioblastoma [Kommentar]
  JAMA 315 (21): 2348
• 2016, Stupp R, Toms SA, Kesari S
  Treatment for Patients With Newly Diagnosed Glioblastoma- Reply [Kommentar]
  JAMA 315 (21): 2348-2349
• 2016, Swanson KD, Lok E, Wong ET
  [Details] An Overview of Alternating Electric Fields Therapy (NovoTTF Therapy) for the Treatment of Malignant Glioma [Review]
  Curr Neurol Neurosci Rep 16 (1): 8-
• 2016, Ansstas G, Tran DD
  Treatment with Tumor-Treating Fields Therapy and Pulse Dose Bevacizumab in Patients with Bevacizumab-Refractory Recurrent Glioblastoma: A Case Series [Grundlagen]
  Case Rep Neurol 8 (1): 1-9
• 2016, Mohan S, Chawla S, Wang S, Verma G, Skolnik A, Brem S, Peters KB, Poptani H
  Assessment of early response to tumor-treating fields in newly diagnosed glioblastoma using physiologic and metabolic MRI: initial experience [med./bio.]
  CNS Oncol 5 (3): 137-144
• 2016, Kim EH, Song HS, Yoo SH, Yoon M
  Tumor treating fields inhibit glioblastoma cell migration, invasion and angiogenesis [med./bio.]
  Oncotarget 7 (40): 65125-
• 2016, Kim EH, Kim YJ, Song HS, Jeong YK, Lee JY, Sung J, Yoo SH, Yoon M
  Biological effect of an alternating electric field on cell proliferation and synergistic antimitotic effect in combination with ionizing radiation [med./bio.]
  Oncotarget 7 (38): 62267-
• 2016, Chan AK, Birk HS, Winkler EA, Viner JA, Taylor JW, McDermott MW
  Stability of programmable shunt valve settings with simultaneous use of the Optune transducer array: a case report [Gerät/Impl.]
  Cureus 8 (7): e675-
• 2016, Orban C, Perez-Garcia E, Bajnok A, McBean G, Toldi G, Blanco-Fernandez A
  Real time kinetic flow cytometry measurements of cellular parameter changes evoked by nanosecond pulsed electric field [med./bio.]
  Cytometry A 89 (5): 472-479
• 2016, Huang YJ, Hoffmann G, Wheeler B, Schiapparelli P, Quinones-Hinojosa A, Searson P
  Cellular microenvironment modulates the galvanotaxis of brain tumor initiating cells [med./bio.]
  Sci Rep 6: 21583
• 2016, Wenger C, Salvador R, Basser PJ, Miranda PC
  Improving Tumor Treating Fields Treatment Efficacy in Patients With Glioblastoma Using Personalized Array Layouts [tech./dosim.]
  Int J Radiat Oncol Biol Phys 94 (5): 1137-1143
• 2016, Kalakoti P, Murray RD, Pettersson-Segerlind J, Smeds H, Nanda A
  Cochlear implants in the etiopathogenesis of glioblastoma-an interesting observation or independent finding? [Grundlagen]
  Acta Neurochir 158 (5): 907-912
• 2015, Lok E, Hua V, Wong ET
  Computed modeling of alternating electric fields therapy for recurrent glioblastoma [tech./dosim.]
  Cancer Med 4 (11): 1697-1699
• 2015, Wenger C, Salvador R, Basser PJ, Miranda PC
  The electric field distribution in the brain during TTFields therapy and its dependence on tissue dielectric properties and anatomy: a computational study [tech./dosim.]
  Phys Med Biol 60 (18): 7339-7357
• 2015, Sampson JH
  Alternating Electric Fields for the Treatment of Glioblastoma [Kommentar]
  JAMA 314 (23): 2511-2513
• 2015, Stupp R, Taillibert S, Kanner AA, Kesari S, Steinberg DM, Toms SA, Taylor LP, Lieberman F, Silvani A, Fink KL, Barnett GH, Zhu JJ, Henson JW, Engelhard HH, Chen TC, Tran DD, Sroubek J, Tran ND, Hottinger AF, Landolfi J, Desai R, Caroli M, Kew Y, Honnorat J, Idbaih A, Kirson ED, Weinberg U, Palti Y, Hegi ME, Ram Z
  Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial [med. Anw.]
  JAMA 314 (23): 2535-2543
• 2015, Taillibert S, Le Rhun E, Chamberlain MC
  [Details] Tumor treating fields: a new standard treatment for glioblastoma? [Review]
  Curr Opin Neurol 28 (6): 659-664
• 2015, Wong ET, Toms SA, Ahluwalia MS
  Technological advances in the treatment of cancer: combining modalities to optimize outcomes [Grundlagen]
  Clin Adv Hematol Oncol 13 (11) Suppl: 1-18
• 2015, Bomzon Z, Urman N, Wenger C, Giladi M, Weinberg U, Wasserman Y, Kirson ED, Miranda PC, Palti Y
  Modelling Tumor Treating Fields for the treatment of lung-based tumors [tech./dosim.]
  2015 37th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), Milan, Italy. IEEE: S. 6888-6891; ISBN 978-1-4244-9271-8
• 2015, Wenger C, Giladi M, Bomzon Z, Salvador R, Basser PJ, Miranda PC
  Modeling Tumor Treating Fields (TTFields) application in single cells during metaphase and telophase [tech./dosim.]
  2015 37th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), Milan, Italy. IEEE: S. 6892-6895; ISBN 978-1-4244-9271-8
• 2015, Chaudhry A, Benson L, Varshaver M, Farber O, Weinberg U, Kirson E, Palti Y
  NovoTTF-100A system (Tumor Treating Fields) transducer array layout planning for glioblastoma: a NovoTAL system user study [med. Anw.]
  World J Surg Oncol 13: 316
• 2015, Winter L, Oezerdem C, Hoffmann W, van de Lindt T, Periquito J, Ji Y, Ghadjar P, Budach V, Wust P, Niendorf T
  Thermal magnetic resonance: physics considerations and electromagnetic field simulations up to 23.5 Tesla (1GHz) [tech./dosim.]
  Radiat Oncol 10: 201
• 2015, Liu YX, Li GQ, Fu XP, Xue JH, Ji SP, Zhang ZW, Zhang Y, Li AM
  [Details] Exposure to 3G mobile phone signals does not affect the biological features of brain tumor cells [med./bio.]
  BMC Public Health 15: 764
• 2015, Wong ET, Lok E, Swanson KD
  [Details] An Evidence-Based Review of Alternating Electric Fields Therapy for Malignant Gliomas [Review]
  Curr Treat Options Oncol 16 (8): 40
• 2014, Lacouture ME, Davis ME, Elzinga G, Butowski N, Tran D, Villano JL, DiMeglio L, Davies AM, Wong ET
  Characterization and management of dermatologic adverse events with the NovoTTF-100A System, a novel anti-mitotic electric field device for the treatment of recurrent glioblastoma [med. Anw.]
  Semin Oncol 41: S1-S14
• 2014, Elzinga G, Wong ET
  Resolution of cystic enhancement to add-on tumor treating electric fields for recurrent glioblastoma after incomplete response to bevacizumab [med. Anw.]
  Case Rep Neurol 6 (1): 109-115
• 2014, Vymazal J, Wong ET
  Response patterns of recurrent glioblastomas treated with tumor-treating fields [med. Anw.]
  Semin Oncol 41: S14-S24
• 2014, Giladi M, Schneiderman RS, Porat Y, Munster M, Itzhaki A, Mordechovich D, Cahal S, Kirson ED, Weinberg U, Palti Y
  Mitotic disruption and reduced clonogenicity of pancreatic cancer cells in vitro and in vivo by tumor treating fields [med./bio.]
  Pancreatology 14 (1): 54-63
• 2014, Miranda PC, Mekonnen A, Salvador R, Basser PJ
  Predicting the electric field distribution in the brain for the treatment of glioblastoma [tech./dosim.]
  Phys Med Biol 59 (15): 4137-4147
• 2014, Wong ET, Lok E, Swanson KD, Gautam S, Engelhard HH, Lieberman F, Taillibert S, Ram Z, Villano JL
  Response assessment of NovoTTF-100A versus best physician's choice chemotherapy in recurrent glioblastoma [med. Anw.]
  Cancer Med 3 (3): 592-602
• 2014, Carlberg M, Hardell L
  [Details] Decreased Survival of Glioma Patients with Astrocytoma Grade IV (Glioblastoma Multiforme) Associated with Long-Term Use of Mobile and Cordless Phones [epidem.]
  Int J Environ Res Public Health 11 (10): 10790-10805
• 2014, Akhavan-Sigari R, Baf MM, Ariabod V, Rohde V, Rahighi S
  [Details] Connection between Cell Phone use, p53 Gene Expression in Different Zones of Glioblastoma Multiforme and Survival Prognoses [med./bio.]
  Rare Tumors 6 (3): 5350
• 2014, Morgan LL, Kesari S, Davis DL
  [Details] Why children absorb more microwave radiation than adults: The consequences [Review]
  J Microsc Ultrastruct 2 (4): 197-204
• 2014, Turner SG, Gergel T, Wu H, Lacroix M, Toms SA
  The effect of field strength on glioblastoma multiforme response in patients treated with the NovoTTFTM-100A system [med. Anw.]
  World J Surg Oncol 12: 162
• 2014, Ostrom QT, Bauchet L, Davis FG, Deltour I, Fisher JL, Langer CE, Pekmezci M, Schwartzbaum JA, Turner MC, Walsh KM, Wrensch MR, Barnholtz-Sloan JS
  [Details] The epidemiology of glioma in adults: a "state of the science" review [Review]
  Neuro Oncol 16 (7): 896-913
• 2014, Teodori L, Giovanetti A, Albertini MC, Rocchi M, Perniconi B, Valente MG, Coletti D
  Static magnetic fields modulate X-ray-induced DNA damage in human glioblastoma primary cells [med./bio.]
  J Radiat Res 55 (2): 218-227
• 2013, Butowski N, Wong ET, Mehta MP, Wilson LK
  A roundtable discussion on the clinical challenges and options for the treatment of glioblastoma: introducing a novel modality, TTFields [Grundlagen]
  Semin Oncol 40 (6): S2-S4
• 2013, Marsh GM, Youk AO, Buchanich JM, Xu H, Downing S, Kennedy KJ, Esmen NA, Hancock RP, Lacey SE, Fleissner ML
  Long-term health experience of jet engine manufacturing workers: VI: incidence of malignant central nervous system neoplasms in relation to estimated workplace exposures [epidem.]
  J Occup Environ Med 55 (6): 654-675
• 2013, Mihailovic G, Markovic M, Zivkovic N, Mihailovic G, Markovic M, Berisavac I, Spaic M
  [Epidemiological features of brain tumors] [fremdsprachig]
  Srp Arh Celok Lek 141 (11-12): 823-829
• 2013, Roviello G, Petrioli R, Cerase A, Marsili S, Miracco C, Rubino G, Tini P
  A husband and a wife with simultaneous presentation of glioblastoma multiforme: a case report [Grundlagen]
  Case Rep Oncol 6 (3): 538-543
• 2013, Omuro A, DeAngelis LM
  [Details] Glioblastoma and other malignant gliomas: a clinical review [Review]
  JAMA 310 (17): 1842-1850
• 2013, Hardell L, Carlberg M
  [Details] Use of mobile and cordless phones and survival of patients with glioma [epidem.]
  Neuroepidemiology 40 (2): 101-108
• 2013, Davies AM, Weinberg U, Palti Y
  Tumor treating fields: a new frontier in cancer therapy [med. Anw.]
  Ann N Y Acad Sci 1291: 86-95
• 2013, Villano JL, Williams LE, Watson KS, Ignatius N, Wilson MT, Valyi-Nagy T, Michals EA, Engelhard HH
  Delayed response and survival from NovoTTF-100A in recurrent GBM [med. Anw.]
  Med Oncol 30 (1): 338
• 2013, Nieder C
  Ergebnisse einer randomisierten Phase-III-Studie zur Behandlung rezidivierter Glioblastome: NovoTTF-100A versus Chemotherapie [Kommentar]
  Strahlenther Onkol 189 (1): 93-94
• 2013, Hardell L, Carlberg M, Hansson Mild K
  [Details] Use of mobile phones and cordless phones is associated with increased risk for glioma and acoustic neuroma [Review]
  Pathophysiology 20 (2): 85-110
• 2012, De Bonis P, Doglietto F, Anile C, Pompucci A, Mangiola A
  Electric fields for the treatment of glioblastoma [med. Anw.]
  Expert Rev Neurother 12 (10): 1181-1184
• 2012, Fonkem E, Wong ET
  NovoTTF-100A: a new treatment modality for recurrent glioblastoma [med. Anw.]
  Expert Rev Neurother 12 (8): 895-899
• 2012, Stupp R, Wong ET, Kanner AA, Steinberg D, Engelhard H, Heidecke V, Kirson ED, Taillibert S, Liebermann F, Dbaly V, Ram Z, Villano JL, Rainov N, Weinberg U, Schiff D, Kunschner L, Raizer J, Honnorat J, Sloan A, Malkin M, Landolfi JC, Payer F, Mehdorn M, Weil RJ, Pannullo SC, Westphal M, Smrcka M, Chin L, Kostron H, Hofer S, Bruce J, Cosgrove R, Paleologous N, Palti Y, Gutin PH
  NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality [med. Anw.]
  Eur J Cancer 48 (14): 2192-2202